Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein.
Acta Pharmacol Sin
; 43(4): 788-796, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34349236
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Spike Glycoprotein, Coronavirus
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
China